Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of Ga-68 Dolacga Scintigraphy to Evaluate Liver Reserve Function in Patients With Hepatocellular Carcinoma Before and After Proton Therapy

NCT06182865 is registered in ClinicalTrials.gov with National Atomic Research Institute, Taiwan as lead sponsor.

NCT NCT06182865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06182865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of Ga-68 Dolacga Scintigraphy to Evaluate Liver Reserve Function in Patients With Hepatocellular Carcinoma Before and After Proton Therapy
Lead sponsor
National Atomic Research Institute, Taiwan
Phase
Not applicable
Overall status
Unknown status
Start date
December 20, 2023
Completion date
December 30, 2024
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic carcinoma